General Information of the Compound
Compound ID |
CP0645891
|
||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Compound Name |
1-(Benzylamino)ethaniminium bromide
Show/Hide
|
||||||||||||||||||
Synonyms |
(1E)-N'-Benzylethanimidamide--hydrogen bromide (1/1)
1-(Benzylamino)ethaniminium bromide
186545-76-6
1916AH
AKOS025294782
C9H12N2.HBr
CHEMBL462334
CTK8E6104
DTXSID10649404
J-011977
MolPort-009-019-600
N-Benzylacetamidine Hydrobromide
N-benzylacetimidamide hydrobromide
RT-023317
Show/Hide
|
||||||||||||||||||
Structure |
|
||||||||||||||||||
Formula |
C9H13BrN2
|
||||||||||||||||||
Molecular Weight |
229.121
|
||||||||||||||||||
Canonical SMILES |
Br.CC(=N)NCc1ccccc1
Show/Hide
|
||||||||||||||||||
InChI |
InChI=1S/C9H12N2.BrH/c1-8(10)11-7-9-5-3-2-4-6-9;/h2-6H,7H2,1H3,(H2,10,11);1H
Show/Hide
|
||||||||||||||||||
InChIKey |
RUQJDXJQOUUQHG-UHFFFAOYSA-N
|
||||||||||||||||||
Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
PubChem ID | |||||||||||||||||||
ChEMBL ID |
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
---|
Table of Molecular Bioactivities Related to the Compound
Clinical Information about the Compound